Hydroxychloroquine & Lupus

Slides:



Advertisements
Similar presentations
Line Efficiency     Percentage Month Today’s Date
Advertisements

Unit Number Oct 2011 Nov 2011 Dec 2011 Jan 2012 Feb 2012 Mar 2012 Apr 2012 May 2012 Jun 2012 Jul 2012 Aug 2012 Sep (3/4 Unit) 7 8 Units.
ProjectImpactResourcesDeadlineResourcesDeadline Forecast Plan Time Resources Risk 001xx 002xx 003xx 004xx 005xx 006xx 007xx TotalXX Example 1: Portfolio.
Clinical Relevance of Hyperuricemia
Autoimmune Disorders During Pregnancy -Lupus -Antiphospholipid syndrome Rovnat Babazade, MD Obstetrical Anesthesia-2016.
Jan 2016 Solar Lunar Data.
Algorithm for diagnosis and initial therapy of systemic lupus erythematosus (SLE). For guidelines on management of lupus and lupus nephritis, see BH Hahn.

Q1 Jan Feb Mar ENTER TEXT HERE Notes

Project timeline # 3 Step # 3 is about x, y and z # 2
Average Monthly Temperature and Rainfall
Apr-Jun Jan-Mar Jul-Sep Oct-Dec


Dollar Guidance CI (A) Total RQTs (B) Directed RQTs (C) Remaining RQTs
Less Important RemainingRQTs

US Preventive Services Task Force. Ann Intern Med 2009;150:
Mammoth Caves National Park, Kentucky
2017 Jan Sun Mon Tue Wed Thu Fri Sat

FOMEMA Sales Review Clinic Management Meeting
Gantt Chart Enter Year Here Activities Jan Feb Mar Apr May Jun Jul Aug
Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Free PPT Diagrams : ALLPPT.com

(A) Lequesne index and quadriceps strength of patients with knee OA

Window of Opportunity in RA
Step 3 Step 2 Step 1 Put your text here Put your text here
Updated 2016 PsA Core Domain Set.
Jan Sun Mon Tue Wed Thu Fri Sat


Infections and Biologic Therapy in Rheumatoid Arthritis

Electricity Cost and Use – FY 2016 and FY 2017

Enrollment and Outcomes
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Free PPT Diagrams : ALLPPT.com


Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Less Important RemainingRQTs
Name that bone....
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Text for section 1 1 Text for section 2 2 Text for section 3 3
Project timeline # 3 Step # 3 is about x, y and z # 2
TIMELINE NAME OF PROJECT Today 2016 Jan Feb Mar Apr May Jun
Mean (95% CI) fasting s-glucose at baseline and 6-month, 12-month, and 24-month follow-up, overall and by sex (A), and by baseline age (B), education (C),

Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Kaplan-Meier survival plot for primary endpoint of arthritis development. Kaplan-Meier survival plot for primary endpoint of arthritis development. Arthritis-free.
Increased numbers of LDGs in association with disease activity and low complement levels in patients with SLE. Numbers of LDGs were determined by flow.
(A) JIA-ACR30/50/70/90 response rates by visit in part 1.
Effect sizes (95% CI) of clinical variables per treatment group of studies directly comparing different dosages/routes. Effect sizes (95% CI) of clinical.
Mean disease activity score based on a 28-joint count (DAS28 (ESR)) (A), Clinical Disease Activity Index (CDAI) score (B) and Simplified Disease Activity.
Serial determinations of both anti-chromatin and anti-dsDNA antibodies in a patient who developed lupus nephropathy during the study period, showing that.
 Ultrasonographic picture of second metatarsophalangeal joint with synovitis (panel A) and without synovitis (panel B). a, metatarsal head; b, base of.
Change Management E2E Roadmap
Patient disposition. *n=1 patient took prohibited concomitant medication due to an adverse event and was discontinued from the study. Patient disposition.
Presentation transcript:

Hydroxychloroquine & Lupus Decreases cardiac/neonatal lupus (OR 0.28, 95% CI 0.12-0.63) Ann Rheum Dis. 2010 Oct;69(10):1827-30 Lowers fasting glucose and improved insulin resistance J Rheum. 2010 Jun;37(6):1136-42). Decreased risk of Thromboembolic events (OR 0.31, 95% CI 0.13-0.71) Arthritis Rheum. 2010 Mar;62(3):863-8. Improves survival (OR 0.128, 95% CI 0.054-0.301) Ann Rheum Dis. 2007 Sep;66(9):1168-72. LUMINA Cohort Decreases clinical flares N Engl J Med. 1991 Jan 17;324(3):150-4. ♀ Zhu A&R 2011;63:3136 Zhang. ARD 2013 Jan 23 Taylor. Am J Med. 2012;125:1126 Zhang. A&R 2012;64:4004 Choi H. BMJ. 2012;12;344 Kuo CF. Joint Bone Spine. 2012;79:375. DeVera Arthritis Rheum. 2008;59:1549